Genetic variants in recurrent euploid pregnancy loss

Abstract Background Recurrent pregnancy loss (RPL) affects ~ 5% of couples. Known causes of RPL include aneuploidies and unbalanced chromosome rearrangements, however the genetic basis of losses with normal karyotype and chromosomal microarray analysis remains unclear. We hypothesized that deleterious variants in genes essential for early development, including genes previously associated only with neonatal lethal disorders, contribute to RPL. Methods Genome sequencing was performed on 118 families with unexplained, euploid RPL; 95% lacked major fetal structural anomalies on ultrasound. A tiered variant prioritization pipeline integrated model organism, human population databases, essential developmental pathways, and fetal transcriptomic profiles. Rare variants (allele frequency ≤ 0.1%) were assessed and confirmed by orthogonal methods. Parental samples were analyzed for mosaicism. Results Pathogenic/likely pathogenic variants were identified in 18 families (15.3%) across 17 genes. These include six families with DHCR7 , PIEZO1 , PIGV , PRF1 , SLC12A3 , and SMN1 biallelic variants; two cases with ALAS2 and IKBKG hemizygous variants; and four pregnancies with heterozygous alterations inherited from affected parents with MYH3 and TNNI3 variants, and from asymptomatic parents with SCN5A and FLT4 variants. Additionally, four families had presumed de novo heterozygous variants in the EFTUD2 , HNRNPK , FGFR2 , and KAT6A genes (associated with autosomal dominant conditions), while two exhibited parental germline mosaicism in the FGFR2 and PORCN genes. Variants of uncertain significance were detected in 12 families (10.2%) across the ABCB7 , CLPB , CRB2 , FBN1 , FLT4 , GJA1 , LYST , MAGED2 , PTPN14 , RNF213 , TLR8 , and VPS35L genes. Of 28 genes with plausible variants, 13 genes were previously implicated in perinatal lethality, whereas 15 were novel candidates. Overall, variants in candidate genes were inherited in 80% of families. Four additional families (3.4%) had biallelic ultra-rare variants in genes, which are involved in fundamental developmental pathways but not yet linked to human disease, pointing to a possible role in prenatal lethality. Transcriptomic analyses supported novel gene involvement in hematopoiesis, cardiovascular development, inflammation, and fluid homeostasis processes. Conclusions Genome sequencing revealed plausible monogenic etiologies for unexplained euploid pregnancy loss, providing new insights into the biology of early human lethality, phenotypic spectra, recurrence risks, and inheritance patterns. These findings support expanding RPL diagnostics beyond karyotyping and chromosomal microarray analysis.

Authors

Institutions

Publication Details

Journal
Genome Medicine
Published
2026-11-15
DOI
https://doi.org/10.1186/s13073-026-01817-5
Citations
2
Primary Topic
Prenatal Screening and Diagnostics
Type
article
Field-Weighted Citation Impact
4.43

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genetic variants in recurrent euploid pregnancy loss

Christina G. Tise, Ruth Bunker Lathi, Mona Amin‐Beidokhti, Elizabeth Pollard et al.
2 citations
Genome Medicine
Prenatal Screening and Diagnostics
4.43
article

Genetic variants in recurrent euploid pregnancy loss

Christina G. Tise, Ruth Bunker Lathi, Mona Amin‐Beidokhti, Elizabeth Pollard, Aleksandar Rajkovic, Marta Rodríguez-Escribà, Michael P. Snyder, Linda C. Giudice, Hakan Çakmak, Gary Michael Shaw, Michelle M. Halstead, Maureen K. Baldwin, Alison B. Edelman, Katrina Merrion, Mary D. Stephenson, Jonathan Adam Bernstein, Marina Sirota, Svetlana A. Yatsenko, David K. Stevenson
article en
2 citations

Abstract

Abstract Background Recurrent pregnancy loss (RPL) affects ~ 5% of couples. Known causes of RPL include aneuploidies and unbalanced chromosome rearrangements, however the genetic basis of losses with normal karyotype and chromosomal microarray analysis remains unclear. We hypothesized that deleterious variants in genes essential for early development, including genes previously associated only with neonatal lethal disorders, contribute to RPL. Methods Genome sequencing was performed on 118 families with unexplained, euploid RPL; 95% lacked major fetal structural anomalies on ultrasound. A tiered variant prioritization pipeline integrated model organism, human population databases, essential developmental pathways, and fetal transcriptomic profiles. Rare variants (allele frequency ≤ 0.1%) were assessed and confirmed by orthogonal methods. Parental samples were analyzed for mosaicism. Results Pathogenic/likely pathogenic variants were identified in 18 families (15.3%) across 17 genes. These include six families with DHCR7 , PIEZO1 , PIGV , PRF1 , SLC12A3 , and SMN1 biallelic variants; two cases with ALAS2 and IKBKG hemizygous variants; and four pregnancies with heterozygous alterations inherited from affected parents with MYH3 and TNNI3 variants, and from asymptomatic parents with SCN5A and FLT4 variants. Additionally, four families had presumed de novo heterozygous variants in the EFTUD2 , HNRNPK , FGFR2 , and KAT6A genes (associated with autosomal dominant conditions), while two exhibited parental germline mosaicism in the FGFR2 and PORCN genes. Variants of uncertain significance were detected in 12 families (10.2%) across the ABCB7 , CLPB , CRB2 , FBN1 , FLT4 , GJA1 , LYST , MAGED2 , PTPN14 , RNF213 , TLR8 , and VPS35L genes. Of 28 genes with plausible variants, 13 genes were previously implicated in perinatal lethality, whereas 15 were novel candidates. Overall, variants in candidate genes were inherited in 80% of families. Four additional families (3.4%) had biallelic ultra-rare variants in genes, which are involved in fundamental developmental pathways but not yet linked to human disease, pointing to a possible role in prenatal lethality. Transcriptomic analyses supported novel gene involvement in hematopoiesis, cardiovascular development, inflammation, and fluid homeostasis processes. Conclusions Genome sequencing revealed plausible monogenic etiologies for unexplained euploid pregnancy loss, providing new insights into the biology of early human lethality, phenotypic spectra, recurrence risks, and inheritance patterns. These findings support expanding RPL diagnostics beyond karyotyping and chromosomal microarray analysis.

Genome MedicineVol. 18(1)
Oregon Health & Science University (US), University of California, San Francisco (US), University of Illinois Chicago (US), Natera (United States) (US), Stanford Medicine (US), Stanford Maternal and Child Health Research Institute (US), Stanford University (US)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Good health and well-being
Openalex Percentile: Top 13%
Prenatal Screening and Diagnostics
4.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon